Cell Transplantation (Mar 2004)

Intraspinal Transplantation of CD34+ Human Umbilical Cord Blood Cells after Spinal Cord Hemisection Injury Improves Functional Recovery in Adult Rats

  • Zong Mao Zhao,
  • Hong Jun Li,
  • Hai Ying Liu,
  • Shi Hong Lu,
  • Ren Chi Yang,
  • Qing Jun Zhang,
  • Zhong Chao Han

DOI
https://doi.org/10.3727/000000004773301780
Journal volume & issue
Vol. 13

Abstract

Read online

The present study was designed to compare the functional outcome of the intraspinal transplantation of CD34+ human umbilical cord blood (CB) cells with that of human bone marrow stromal (BMS) cells in adult rats with spinal cord injury. Sixty adult Wistar rats were subjected to left spinal cord hemisection, and then divided into three groups randomly. The control group received an injection of PBS without cells, while the two other groups of rats received a transplantation of 5 × 105 CD34+ CB or BMS cells, respectively. Functional outcome was measured using the modified Tarlov score at days 1, 7, 14, 21, and 28 after transplantation. A statistically significant improvement in functional outcome and survival rate in the experimental groups of rats was observed compared with the control group. Rats that received CD34+ CB cells achieved a better improvement in functional score than those that received BMS cells at days 7 and 14 after transplantation. Histological evaluation revealed that bromodeoxyuridine (BrdU)-labeled CD34+ CB and BMS cells survived and migrated into the injured area. Some of these cells expressed glial fibriliary acidic protein (GFAP) or neuronal nuclear antigen (NeuN). Our data demonstrate for the first time that intraspinal transplantation of human CD34+ CB cells provides benefit in function recovery after spinal cord hemisection in rats and suggest that CD34+ CB cells may be an excellent choice of cells as routine starting material of allogenic and autologous transplantations for the treatment of spinal cord injury.